Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision

Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin

(2012) R. L. Carhart-Harris et al.   BRITISH JOURNAL OF PSYCHIATRY

Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses

(2012) Michael P. Bogenschutz et al.   Drug Testing and Analysis

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

(2012) Teri S Krebs et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Shaping the renaissance of psychedelic research

(2012) Ben Sessa   LANCET

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

(2012) R. L. Carhart-Harris et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions

(2012) André Schmidt et al.   PSYCHOPHARMACOLOGY

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

(2011) Katherine A MacLean et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

(2010) Charles S. Grob et al.   ARCHIVES OF GENERAL PSYCHIATRY

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

(2010) Franz X. Vollenweider et al.   NATURE REVIEWS NEUROSCIENCE

Treating Drug Abuse and Addiction in the Criminal Justice System

(2009) Redonna K. Chandler et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review

(2008) R Mačiulaitis et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Human hallucinogen research: guidelines for safety

(2008) MW Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

(2008) RR Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY